A total of 18 201 patients with AF and a raised risk of stroke were randomized to warfarin or apixaban 5 mg b.d. with dose reduction to 2.5 mg b.d. or placebo in 831 patients with 2 of the following criteria : age 80 years , body weight 60 kg , or creatinine 133 mol/L .